Back

Resolution of systemic inflammation in patients with recently decompensated heart failure with reduced ejection fraction with and without interleukin-1 blockade by anakinra

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers and prognosis in acute heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Antonio Abbate

University of Virginia, Charlottesville (United States of America)

7 More presentations in this session

Presentation thumbnail
Association between high serum uric acid and poor outcomes in patients with acute heart failure.
Doctor F. Qorina (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Diagnostic and prognostic performance of insulin-like growth factor-binding protein 7 in patients with acute dyspnea in the emergency department
Ms C. Popescu (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Genotype-dependent NT-proBNP, cardiac remodeling and pharmacokinetic marker dynamics after acute decompensation in heart failure: insights from the BeLove study
Ms E. Ghanbari (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
The role of exhaled breath acetone and BNP in predicting outcomes in advanced heart failure
Doctor D. Motta Da Costa Dan (Vitoria, BR)
Abstract Slides Video
Presentation thumbnail
Admission natriuresis as a predictor of outcomes in acute decompensated heart failure
Mr J. Iroulart (Buenos Aires, AR)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers and prognosis in acute heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Effects of anakinra on patients with heart failure below and above 60 years of age
thumbnail
Congress Presentation
Interleukin-1 blockade in patients with ST-segment elevation myocardial infarction with and without history of coronary artery disease
thumbnail
Congress Presentation
Pharmacotherapy targeting inflammation in HFpEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources